Tag Archives: webinar

Access to Hep C Treatment in Federal Institutions Webinar

Access to Hep C Treatment in Federal Institutions WebinarThursday, March 23rd at 11am PST,  join CTAC Policy Researcher Amanda Fletcher’s webinar to learn more about the prevalence of hepatitis C in Canada’s federal institutions.*

Hepatitis C impacts between 250,000-300,000 Canadians, among whom at least 44% are undiagnosed and untreated. While the national hep C burden among Canadians is approximately 1%, the prevalence of hep C in correctional institutions is estimated to be between 20 and 40%.

March 23rd CTAC Webinar

This CTAC webinar will focus on issues and recommendations around access to hep C treatment in federal institutions and address questions like: How has treatment, traditionally, been administered? What are the factors behind such a high hep C prevalence rate? What kind of preventative measures can be taken? How have Correctional Service Canada’s drug eligibility restrictions changed, and what does this mean for hep C treatment within the institutional setting?

Learn more about screening; treatment; harm reduction; social determinanents of health (gender, mental health/substance abuse); Correctional Service Canada’s new and less restrictive eligibility requirements around fibrosis scores; and, finally, CTAC’s recommendations for increasing treatment access.

Don’t delay. Register now!

On the day of the event, you will need to log on to the webinar at http://ctac.adobeconnect.com/hepCprison and dial in for the audio toll-free at 877-473-4906 with conference code 4564615148


CTAC is an organization that focuses on access to treatment for people living with HIV and HIV/HCV co-infection. Since 1996, they have worked to secure and ensure equitable, affordable and timely access to treatment, care and support for people in Canada living with HIV and HIV/HCV co-infection.
*Content by CTAC

Strategies to Address Reimbursement Restrictions

Strategies to address reimbursement restrictionsClick here to view a recording of the February 6th webinar Strategies to address reimbursement restrictions for Hep C treatment: Lessons from Australia.

In collaboration with CanHepC, CTAC, and The Kirby Institute in Australia, CATIE organized this webinar to look at strategies to address Canada’s current restrictive and inconsistent approach to direct-acting antiviral (DAA) access and the lessons we can learn from the Australian model.

Learn from experts like Alison Marshall and Greg Dore of Australia’s The Kirby Institute; and Helen Tyrell of Hepatitis Australia. Listen to a discussion between Adam Cook of CTAC and Action Hepatitis Canada’s Community Organizer, Zoe Dodd.


Canadian Treatment Action Council Webinar

sq_trialsOn December 10th @ 11am PST / 2pm EST, the Canadian Treatment Action Council (CTAC) will be hosting an informative webinar with a survey to follow about the hep C treatment ombitasvir/paritaprevir/ritonavir and dasabuvir. The treatment is currently undergoing a CADTH Common Drug Review (CDR), which is now collecting patient input.

The survey that will follow the Canadian Treatment Action Council webinar is different from PHCN’s patient input survey. Please consider filling out both surveys.

Registration for the webinar is required
. Email Adam Cook to register to attend or to get more information about the webinar.

More information about ombitasvir/paritaprevir/ritonavir and dasabuvir can be found at Hep C TIP News or PHCN’s Hepatitis C Treatment Information Project.